close

Agreements

Date: 2017-06-30

Type of information: Nomination

Compound:

Company: Quantum Genomics (France)

Therapeutic area: Cardiovascular diseases

Type agreement: nomination

Action mechanism:

Disease:

Details:

  • • On June 30, 2017, Quantum Genomics announced the appointment of Professor Toshiro Fujita as member of its Scientific Advisory Board. Professor Toshiro Fujita is Professor of the Department of Clinical Epigenetics, RCAST, The University of Tokyo and Director, CREST, JST Strategic Basic Research Program. He conducted numerous researches in salt-sensitive hypertension. He is member of HBPR Leadership Committee, former President of the Japanese Society of Hypertension and Vice-President of the International Society of Hypertension. Together with Professor Mark Caulfield, Professor Keith C. Ferdinand and Professor Alexandre Persu, he will provide recommendations regarding the Research & Development programs of Quantum Genomics.

Financial terms:

Latest news:

Is general: Yes